Sunday, February 8, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Anticipated Earnings Release and Stock Performance for Central Puerto NYSE CEPU

Elaine Mendonca by Elaine Mendonca
March 7, 2024
in Breaking News
0
EEFT stock news
0
SHARES
6
VIEWS
Share on FacebookShare on Twitter

Central Puerto (NYSE: CEPU) is anticipated to announce an earnings per share (EPS) of $0.01 for the upcoming quarter. Investors are eagerly awaiting the company’s guidance on future growth, as this could have a significant impact on stock prices.

In the previous quarter, Central Puerto surpassed EPS estimates by $0.07, leading to a 0.0% decrease in share price the following day. Reflecting on past quarters:
Q3 2023: EPS Actual $0.10, Price Change +2.0%
Q2 2023: EPS Actual $0.14, Price Change +3.0%
Q1 2023: EPS Actual $0.01, Price Change -3.0%
Q4 2022: EPS Actual $0.10, Price Change -8.0%.

As of March 5, Central Puerto’s shares were trading at $8.04, demonstrating a positive trend with a 49.17% increase over the last 52 weeks. Long-term investors are likely feeling optimistic about the upcoming earnings release given these favorable returns.

To access more detailed information and track all earnings releases for Central Puerto, you can refer to their earnings calendar on various financial platforms.

CEPU Stock Price Decreases by 2.36% Following After-Hours Trading Decline

On March 7, 2024, CEPU stock saw a decrease in price momentum, trading in the middle of its 52-week range and above its 200-day simple moving average. The stock closed at $7.85, marking a decrease of $0.19 or 2.36% since the market last closed.

After-hours trading saw a further drop in CEPU stock price, with the stock falling by $0.24. This decline in price indicates that investors may have been selling off their shares, possibly in response to negative news or market conditions.

CEPU Stock Performance: Revenue and Net Income Show Significant Growth in Past Year, Slight Decline in Third Quarter

On March 7, 2024, CEPU stock performance was closely watched by investors as the company reported its financial results for the past year and the third quarter. According to data from CNN Money, CEPU’s total revenue for the past year was $775.39 million, showing a 29.34% increase compared to the previous year. In the third quarter, the total revenue was $185.81 million, representing an 11.8% increase from the previous quarter. The net income for the past year was $145.61 million, showing a significant increase of 1968.26% compared to the previous year. However, in the third quarter, the net income was $14.32 million, which was a decrease of 29.14% from the previous quarter. Earnings per share (EPS) for the past year were $0.97, showing a substantial increase of 1967.76% compared to the previous year. In the third quarter, the EPS was $0.10, which represented a decrease of 29.11% from the previous quarter. Overall, CEPU’s financial performance showed significant growth in total revenue and net income over the past year. However, there was a slight decline in net income and EPS in the third quarter compared to the previous quarter. Investors will be closely monitoring CEPU’s future performance to see if the company can sustain its growth trajectory and continue to deliver strong financial results.

Tags: CEPU
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Biotechnology Markets and money

Werewolf Therapeutics NASDAQ HOWL Q4 Earnings Report Highlights and Future Outlook

Telecommunications Industry stock Trading

Title Saga Communications Reports Quarterly Earnings Exceeding Expectations Despite YearOverYear Decline

Biotechnology Stock Bull Market

Steve Jobs Iconic 4 Check Up for Auction A Piece of Apple History

Recommended

FCBC stock news

Impax Asset Management Group plc Reduces Stake in Snap Inc. as Insiders Sell Off Shares

2 years ago
The Trade Desk Stock

The Trade Desk: A Market Conundrum of Conflicting Signals

3 months ago
Intel Stock

US Government Holds Massive Intel Share Position, Creating Market Uncertainty

5 months ago
Nuvalent Stock

Nuvalent Shares Surge on Promising Clinical Trial Results

3 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Tax Clarity and Sector Optimism Bolster Outlook for Chicago Atlantic

RBB Bancorp Reports Strong Asset Quality Improvement and Strategic Capital Review

Cassava Sciences Confirms Alzheimer Drug Failure and Faces Regulatory Delays

DroneShield Shares Face Headwinds Despite Record Performance

Rock Tech Lithium: Investors Await the Final Go-Ahead

Puma Biotechnology Sets Date for Full-Year Financial Disclosure

Trending

KemPharm Stock
Analysis

Zevra Therapeutics Advances Rare Disease Portfolio with New Data and Strategic Expansion

by Kennethcix
February 8, 2026
0

Zevra Therapeutics continues to build its profile as a dedicated rare disease company. Recent clinical data presentations...

Oak Valley Stock

Oak Valley Bancorp Surpasses $2 Billion Milestone with Record Annual Profit

February 8, 2026
SuRo Capital Stock

SuRo Capital Sharpens Focus on AI Infrastructure Investments

February 8, 2026
Chicago Atlantic Real Estate Finance Stock

Tax Clarity and Sector Optimism Bolster Outlook for Chicago Atlantic

February 8, 2026
RBB Stock

RBB Bancorp Reports Strong Asset Quality Improvement and Strategic Capital Review

February 8, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Zevra Therapeutics Advances Rare Disease Portfolio with New Data and Strategic Expansion
  • Oak Valley Bancorp Surpasses $2 Billion Milestone with Record Annual Profit
  • SuRo Capital Sharpens Focus on AI Infrastructure Investments

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com